Cryo-EM for Drug Discovery: How AIDD Is Transforming Pharma

The Cryo-EM Drug Discovery Revolution

Since the "resolution revolution" of 2013, cryo-EM has become the dominant technique for determining protein structures relevant to drug discovery. Unlike X-ray crystallography, cryo-EM doesn't require crystals, works with smaller amounts of protein, and can capture multiple conformational states.

Why Cryo-EM Excels for Drug Discovery

1. Membrane Proteins and GPCRs

Over 60% of FDA-approved drugs target membrane proteins, especially GPCRs. Cryo-EM can determine GPCR structures in complex with G proteins and arrestins — the signaling conformations most relevant for drug design.

Shuimu has solved structures of GPR75, serotonin receptors, dopamine receptors, somatostatin receptors, and many more.

2. Antibody Structure and Engineering

Cryo-EM reveals antibody-antigen complexes at near-atomic resolution, enabling rational antibody engineering. Epitope mapping, paratope analysis, and Fc engineering all benefit from structural data.

3. Structure-Based Drug Design (SBDD)

With resolutions routinely reaching 2-3Å, cryo-EM maps allow:

• Identification of druggable pockets
• Visualization of bound water molecules
• Detection of allosteric binding sites
• Fragment-based drug design

Enter AIDD: AI-Driven Drug Discovery

AIDD combines structural biology data with machine learning to:

1. Predict binding affinity: Deep learning models trained on cryo-EM structures predict how well a compound binds
2. Generate novel molecules: Generative AI designs new compounds targeting specific pockets
3. Optimize leads: AI-driven docking and scoring accelerate hit-to-lead optimization
4. Predict selectivity: Structural comparisons across receptor subtypes predict off-target effects

Shuimu's AIDD Approach

At Shuimu Biosciences, we integrate cryo-EM structure determination with AI-driven analysis:

• modelSMART: Our proprietary deep learning algorithm for atomic model building from cryo-EM maps
• GraFuture™: Graphene oxide grids that improve particle distribution, yielding higher-quality data for AI training
• High-throughput pipeline: 8x 300kV microscopes generating massive datasets ideal for machine learning

Case Studies

• GPR75: World's first cryo-EM structure of the anti-obesity target, enabling structure-based design
• DNA Pol θ: Novobiocin-bound structure for cancer drug development
• Multiple GPCRs: Drug-target complexes at resolutions suitable for virtual screening

Getting Started

Whether you're a pharmaceutical company looking for a structural biology CRO or a biotech startup exploring AIDD, Shuimu offers flexible service models. Contact us to discuss your drug discovery project.